Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
- PMID: 7966576
- PMCID: PMC237248
- DOI: 10.1128/JVI.68.12.7859-7868.1994
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
Abstract
The molecular basis of strain variation in scrapie diseases is unknown. The only identified component of the agent is the posttranslationally modified host prion protein (PrPSc). The biochemical and physical properties of PrP from two strains of transmissible mink encephalopathy (TME), called hyper (HY) and drowsy (DY), were compared to investigate if PrP heterogeneity could account for strain diversity. The degradation rate of PrPTME digested with proteinase K was found to be strain specific and correlated with inactivation of the TME titer. Edman protein sequencing revealed that the major N-terminal end of HY PrPTME commenced at least 10 amino acid residues prior to that of DY PrPTME after digestion with proteinase K. Analysis of the brain distribution of PrPTME exhibited a strain-specific pattern and localization of PrPTME to the perikarya of specific neuron populations. Our findings are consistent with HY and DY PrPTME having distinct protein conformations and/or strain-specific ligand interactions that influence PrPTME properties. We propose that PrPTME conformation could play a role in targeting TME strains to different neuron populations in which strain-specific formation occurs. These data are consistent with the idea that PrPTME protein structure determines the molecular basis of strain variation.
Similar articles
-
Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.J Virol. 1992 Apr;66(4):2096-101. doi: 10.1128/JVI.66.4.2096-2101.1992. J Virol. 1992. PMID: 1347795 Free PMC article.
-
Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.J Virol. 2000 Jun;74(12):5542-7. doi: 10.1128/jvi.74.12.5542-5547.2000. J Virol. 2000. PMID: 10823860 Free PMC article.
-
Coinfecting prion strains compete for a limiting cellular resource.J Virol. 2010 Jun;84(11):5706-14. doi: 10.1128/JVI.00243-10. Epub 2010 Mar 17. J Virol. 2010. PMID: 20237082 Free PMC article.
-
Prion encephalopathies of animals and humans.Dev Biol Stand. 1993;80:31-44. Dev Biol Stand. 1993. PMID: 8270114 Review.
-
Molecular biology and transgenetics of prion diseases.Crit Rev Biochem Mol Biol. 1991;26(5-6):397-438. doi: 10.3109/10409239109086789. Crit Rev Biochem Mol Biol. 1991. PMID: 1684745 Review.
Cited by
-
Tau strains shape disease.Acta Neuropathol. 2021 Jul;142(1):57-71. doi: 10.1007/s00401-021-02301-7. Epub 2021 Apr 8. Acta Neuropathol. 2021. PMID: 33830330 Free PMC article. Review.
-
EU-approved rapid tests for bovine spongiform encephalopathy detect atypical forms: a study for their sensitivities.PLoS One. 2012;7(9):e43133. doi: 10.1371/journal.pone.0043133. Epub 2012 Sep 11. PLoS One. 2012. PMID: 22984410 Free PMC article.
-
J Proteins Counteract Amyloid Propagation and Toxicity in Yeast.Biology (Basel). 2022 Aug 30;11(9):1292. doi: 10.3390/biology11091292. Biology (Basel). 2022. PMID: 36138771 Free PMC article. Review.
-
Protein misfolding cyclic amplification of prions.J Vis Exp. 2012 Nov 7;(69):4075. doi: 10.3791/4075. J Vis Exp. 2012. PMID: 23168797 Free PMC article.
-
Variant CJD: Reflections a Quarter of a Century on.Pathogens. 2021 Oct 30;10(11):1413. doi: 10.3390/pathogens10111413. Pathogens. 2021. PMID: 34832569 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials